Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration

The discovery of numerous potent and broad neutralizing antibodies (bNAbs) against Human Immunodeficiency Virus type 1 (HIV-1) envelope glycoprotein has invigorated the potential of using them as an effective preventative and therapeutic agent. The majority of the anti-HIV-1 antibodies, currently un...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Vaneet K., Misra, Bijay, McManus, Kevin T., Avula, Sreenivas, Nellaiappan, Kaliappanadar, Caskey, Marina, Horowitz, Jill, Nussenzweig, Michel C., Seaman, Michael S., Javeri, Indu, Dey, Antu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551838/
https://www.ncbi.nlm.nih.gov/pubmed/32751063
http://dx.doi.org/10.3390/antib9030036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551838/
https://www.ncbi.nlm.nih.gov/pubmed/32751063
http://dx.doi.org/10.3390/antib9030036

Ejemplares similares